Healthcare provider profile · identity verified

Yelena Levin, MD

Internal Medicine · TAUNTON, MA · NPI 1225056708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	636	182
Omeprazole	Omeprazole	457	135
Levothyroxine Sodium	Levothyroxine Sodium	428	103
Amlodipine Besylate	Amlodipine Besylate	364	107
Lisinopril	Lisinopril	341	92
Metoprolol Succinate	Metoprolol Succinate	295	84
Alprazolam	Alprazolam	278	64
Hydrochlorothiazide	Hydrochlorothiazide	257	74
Rosuvastatin Calcium	Rosuvastatin Calcium	222	67
Losartan Potassium	Losartan Potassium	219	65
Gabapentin	Gabapentin	216	48
Metformin Hcl	Metformin Hcl	214	68
Pravastatin Sodium	Pravastatin Sodium	206	57
Atenolol	Atenolol	176	50
Sertraline Hcl	Sertraline Hcl	176	46
Simvastatin	Simvastatin	157	48
Eliquis	Apixaban	129	32
Trazodone Hcl	Trazodone Hcl	126	40
Fluoxetine Hcl	Fluoxetine Hcl	117	35
Albuterol Sulfate Hfa	Albuterol Sulfate	106	34
Famotidine	Famotidine	94	29
Lorazepam	Lorazepam	93	20
Tramadol Hcl	Tramadol Hcl	89	19
Clonazepam	Clonazepam	82	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	16
Citalopram Hbr	Citalopram Hydrobromide	81	21
Furosemide	Furosemide	81	33
Pantoprazole Sodium	Pantoprazole Sodium	81	22
Potassium Chloride	Potassium Chloride	80	26
Escitalopram Oxalate	Escitalopram Oxalate	74	19
Prednisone	Prednisone	73	49
Glimepiride	Glimepiride	70	24
Spironolactone	Spironolactone	70	17
Paroxetine Hcl	Paroxetine Hcl	68	16
Ibuprofen	Ibuprofen	63	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Meloxicam	Meloxicam	57	17
Celecoxib	Celecoxib	52	suppressed
Alendronate Sodium	Alendronate Sodium	51	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	14
Metoprolol Tartrate	Metoprolol Tartrate	51	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Montelukast Sodium	Montelukast Sodium	50	16
Oxycodone Hcl	Oxycodone Hcl	50	15
Lovastatin	Lovastatin	49	13
Mirtazapine	Mirtazapine	49	12
Ezetimibe	Ezetimibe	47	11
Ozempic	Semaglutide	46	12
Duloxetine Hcl	Duloxetine Hcl	45	14
Tamsulosin Hcl	Tamsulosin Hcl	45	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	35
Glipizide	Glipizide	44	12
Allopurinol	Allopurinol	42	14
Fluticasone Propionate	Fluticasone Propionate	41	19
Buspirone Hcl	Buspirone Hcl	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	11
Glipizide Er	Glipizide	38	12
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Levetiracetam	Levetiracetam	36	suppressed
Nystatin	Nystatin	35	15
Amitriptyline Hcl	Amitriptyline Hcl	34	12
Jardiance	Empagliflozin	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	12
Ondansetron Odt	Ondansetron	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Baclofen	Baclofen	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Azithromycin	Azithromycin	24	21
Bumetanide	Bumetanide	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Felodipine Er	Felodipine	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Lacosamide	Lacosamide	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Naproxen	Naproxen	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Nabumetone	Nabumetone	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Fluconazole	Fluconazole	16	14
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Cetirizine Hcl	Cetirizine Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error